Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma
Article in Journal of Biological Chemistry (May 2023)
The most recent citing publications are shown below. View all 60 publications that cite this research output on Dimensions.
Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
Article in Frontiers in Oncology (May 2023)
In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model
Article in International Journal of Pharmaceutics X (November 2022)